Crossmark

Pan-immune-inflammation value in lung cancer: prognostic significance and implications for therapeutic guidance — a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12957-025-03910-2

Published Online: 2025-06-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hong, Shuailing

Liu, Jingting

Cheng, Jun

Meng, Chunyan

Liu, Baoqing

Liao, Jianhua
License Information

Text and Data Mining valid from 2025-06-23

Version of Record valid from 2025-06-23
More Information

Article History

Received: 12 April 2025

Accepted: 18 June 2025

First Online: 23 June 2025

Declarations

:

: Not applicable, this study utilized data from publicly available open-access databases and was therefore exempt from formal ethical approval and consent requirements.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below